Last Updated on December 15, 2024 by The Health Master
Piramal Pharma
Piramal Pharma, a leading global pharmaceutical company, has recently announced a settlement agreement with US-based VetDC, Inc.
The agreement involves a payment of USD 407,400 to resolve a dispute concerning rejected product batches.
Key Points of the Settlement:
- Dispute Resolution: Piramal Pharma’s subsidiary, Piramal Pharma Solutions Inc., and VetDC, Inc. have reached a mutual agreement to settle the legal dispute.
- Financial Implications: The settlement amount of USD 407,400 is not expected to significantly impact the company’s overall financial position.
- Strategic Decision: While Piramal Pharma maintains its stance on the legal merits of the case, the decision to settle was made to avoid the costs and uncertainties associated with prolonged litigation.
A Look at Piramal Pharma’s Recent Performance
Despite the settlement, Piramal Pharma continues to demonstrate strong financial performance.
In October, the company reported a remarkable fourfold increase in consolidated net profit for the second quarter of the fiscal year.
About Piramal Pharma
Piramal Pharma is a global pharmaceutical company that offers a diverse range of products and services.
With a strong focus on innovation and quality, the company serves customers in over 100 countries through its extensive global network.
-
Why did Piramal Pharma settle the dispute?
Piramal Pharma chose to settle the dispute to avoid the costs and uncertainties associated with prolonged litigation.
-
How will the settlement impact Piramal Pharma’s financial performance?
The settlement is not expected to have a significant impact on the company’s financial position.
-
What are Piramal Pharma’s core business areas?
Piramal Pharma’s core business areas include contract development and manufacturing, complex hospital generics, and over-the-counter products.
- Piramal Pharma, Piramal Pharma settlement, Piramal Pharma news, Pharmaceutical company news, Legal dispute settlement, Pharmaceutical industry news, Piramal Pharma financial performance, Contract development and manufacturing, Complex hospital generics, Over-the-counter products, OTC Drugs,
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
India Boosts Pharma Manufacturing with Rs 15,000 Crore PLI Scheme
Key Notes on Revised Schedule M: Point No. 3 – Good Manufacturing Practice (GMP)
AIDCOC Seeks Revocation and Investigation on Karnataka Drug Controller Suspension
Himachal Pradesh cracks down on NSQ Drugs Manufacturers
USFDA approval granted for Latanoprost Ophthalmic Solution
DCOIWA appeals for reinstatement of State Drugs Controller Karnataka
Key Notes on Revised Schedule M: Point No. 2 – Quality Risk Management
How to become a Pharmacist in America ?
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
